Fecal incontinence and chronic constipation are common health problems among many adults and children. Manufacturers are developing innovative anal irrigation systems that help individuals and healthcare providers prevent chronic constipation and support efficient bowel management. The growing geriatric population worldwide is more prone to constipation, fecal incontinence, and other neurological disorders, helping to propel the anal irrigation systems market. The anal irrigation systems have proven to be simple, safe, and effective in treating fecal incontinence and are also cost-effective.
Coloplast Group and B. Braun Melsungen AG – Notable Market Players in Europe Anal Irrigation Systems Market
The Europe anal irrigation systems market majorly consists of the players such as BD, ConvaTec Group Plc, Consure Medical, Inc., Coloplast Group, B. Braun Melsungen AG, Renew Medical Inc., MBH-International A/S, DENTSPLY SIRONA Inc., ProSys International Ltd, UROMED Kurt Drews KG amongst others. The companies have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market. The companies have adopted several inorganic and organic strategies to accelerate their growth and improve their market position.
Below is the list of the growth strategies done by the players operating in the Europe anal irrigation systems market:
| Company | Month & Year | Category | Description |
| ConvaTec | May-22 | Mergers and Acquisitions | ConvaTec Group Plc announce that it has completed the acquisition of Triad Life Sciences Inc (‘Triad’). The Triad team, current portfolio and product pipeline will now transition to ConvaTec’s Advanced Wound Care (AWC) business and be known as ConvaTec Advanced Tissue Technologies. |
| Becton, Dickinson, and Company | Apr-22 | Mergers and Acquisitions | Becton, Dickinson and Company, a leading global medical technology company, announced that it has completed its spinoff of Embecta Corp. (embecta), which holds BD’s former Diabetes Care business and is now one of the largest pure-play diabetes management companies in the world. |
| B. Braun | Mar-22 | Mergers and Acquisitions | With the full integration of Intermedt Medizin & Technik GmbH into the Group, B. Braun has completed the extensive product portfolio of its B. Braun Avitum division as a systems provider for extracorporeal blood treatment (dialysis). |
| B. Braun | Jan-22 | Expansion | B. Braun celebrated the official ground-breaking of a state-of-the-art Haemodialysis Concentrate Factory in the Thanh Oai Industrial Complex in Hanoi, Vietnam on January 10, 2022. |
| B. Braun | Nov-21 | Partnership | B. Braun announced a partnership with REVA Medical for the distribution of Fantom Encore – a bioresorbable scaffold for coronary interventions, manufactured with REVA’s patented material Tyrocore. |
| Dentsply Sirona | Jan-21 | Mergers and Acquisitions | DENTSPLY SIRONA Inc. (“Dentsply Sirona”), and Byte, a rapidly growing clear aligner company, today announced that Dentsply Sirona acquired Byte in an all-cash deal for $1.04 billion. |
| Coloplast | Nov-20 | Mergers and Acquisitions | Coloplast announced that it has completed the acquisition of Nine Continents Medical, Inc., an early stage company pioneering an implantable tibial nerve stimulation treatment for over-active bladder. The acquisition price consists of USD 145 million upfront cash payment and an additional contingent future milestone payment. |
| B. Braun | Nov-20 | Partnership | B. Braun Melsungen AG and Grifols form strategic partnership to enhance compounding pharmacy production output and services for hospitals.Grifols is a leading producer of plasma-derived medicines and has compounding centers in U.S. |
| Coloplast | Sep-20 | Expansion | The new factory in Costa Rica is another great milestone in the company’s mission to help those with intimate healthcare needs. The purpose of the factory is to meet the increasing demand by producing and supplying products that will improve the quality of life for many people worldwide,” says Kristian Villumsen, President and CEO of Coloplast. The site is located in Cartago, Costa Rica, and will initially manufacture the company’s ostomy products. The new site supports Coloplast’s ambition of achieving an annual organic growth rate of 7-9% towards 2025. |
| Renew Medical Inc. | Sep-20 | Product Launch | The Renew team are excited to announce the September launch of our latest and significant innovation in Trans Anal Irrigation – The Aquaflush Self Retaining Cone (SRC). The Aquaflush Self Retaining Cone (SRC) is a huge leap forward for cone irrigation, allowing the cone to be retained in position during kit preparation and positioning on the toilet. The Aquaflush SRC was available on prescription from September 1st. |
| Renew Medical Inc. | Jan-20 | Mergers and Acquisitions | Renew Medical Inc. acquired Aquaflush Medical Limited as a part of its long term business strategy for becoming a global leader in markets related to bowel management. This acquisition is among the initial steps of business expansion. The company is coming 12 months is planning to launch its new clinical advisory team, care program, and new product development and innovation strategy. |
| ConvaTec | Sep-2019 | Mergers and Acquisitions | ConvaTec Group Plc signed an agreement to purchase the assets of Southlake Medical Supplies, Inc., a Texas-based independent provider of catheter-related supplies. For the year ended 31 December 2018 Southlake delivered revenues of approximately $5.0 million. |
